These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma]. Ichikawa W; Togo S; Osanai T; Miyanaga T; Sawai S; Yamashita T; Kawachi Y; Nihei Z; Hirayama R; Mishima Y Gan To Kagaku Ryoho; 1994 Sep; 21(13):2212-4. PubMed ID: 7944442 [TBL] [Abstract][Full Text] [Related]
26. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. Kumar A; Srivastava DN; Bal C J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146 [TBL] [Abstract][Full Text] [Related]
27. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma. Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134 [TBL] [Abstract][Full Text] [Related]
28. Intra-arterial radionuclide therapy for liver tumours: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumour uptake and response. Brans B; Bacher K; Vandevyver V; Vanlangenhove P; Smeets P; Thierens H; Dierckx RA; Defreyne L Nucl Med Commun; 2003 Apr; 24(4):391-6. PubMed ID: 12673167 [TBL] [Abstract][Full Text] [Related]
29. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study. Bernal P; Raoul JL; Stare J; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Vidmar G; Buscombe J; Chau TT; Saw MM; Chen S; Ogbac R; Dondi M; Padhy AK Semin Nucl Med; 2008 Mar; 38(2):S40-5. PubMed ID: 18243842 [TBL] [Abstract][Full Text] [Related]
30. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma]. Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687 [TBL] [Abstract][Full Text] [Related]
31. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study. Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884 [TBL] [Abstract][Full Text] [Related]
32. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Lu MD; Yin XY; Xie XY; Xu HX; Xu ZF; Liu GJ; Kuang M; Zheng YL Br J Surg; 2005 Nov; 92(11):1393-8. PubMed ID: 16044409 [TBL] [Abstract][Full Text] [Related]
33. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma. De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257 [TBL] [Abstract][Full Text] [Related]
34. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Wu CC; Cheng SB; Yeh DC; Wang J; P'eng FK Br J Surg; 2009 Sep; 96(9):1049-57. PubMed ID: 19672929 [TBL] [Abstract][Full Text] [Related]
36. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting. Novell JR; Hilson AJ J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486 [No Abstract] [Full Text] [Related]
37. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N; Hanazaki K J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736 [TBL] [Abstract][Full Text] [Related]
38. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131]. Werenne X Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570 [TBL] [Abstract][Full Text] [Related]
39. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599 [TBL] [Abstract][Full Text] [Related]
40. [131-I-lipiodol in therapy of liver carcinoma--methods and case report]. Stefanović L; Nikolić V; Obradović M; Selir Z; Mihoci Z; Mihailović J; Malesević M Med Pregl; 2001; 54(7-8):387-90. PubMed ID: 11905192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]